Published in J Clin Microbiol on February 01, 1994
The physical map of the chromosome of a serogroup A strain of Neisseria meningitidis shows complex rearrangements relative to the chromosomes of the two mapped strains of the closely related species N. gonorrhoeae. J Bacteriol (1995) 3.10
Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest (1994) 1.93
A homologue of the recombination-dependent growth gene, rdgC, is involved in gonococcal pilin antigenic variation. Genetics (2000) 1.83
Microbiological diagnosis of gonorrhoea. Genitourin Med (1997) 1.47
Low-level pilin expression allows for substantial DNA transformation competence in Neisseria gonorrhoeae. Infect Immun (2003) 1.26
Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC. Front Microbiol (2011) 1.26
Comparisons between colony phase variation of Neisseria gonorrhoeae FA1090 and pilus, pilin, and S-pilin expression. Infect Immun (1998) 1.17
Loss of both Holliday junction processing pathways is synthetically lethal in the presence of gonococcal pilin antigenic variation. Mol Microbiol (2006) 1.15
Frequency of pilin antigenic variation in Neisseria gonorrhoeae. J Bacteriol (1998) 1.12
Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun (2005) 1.11
A real-time semi-quantitative RT-PCR assay demonstrates that the pilE sequence dictates the frequency and characteristics of pilin antigenic variation in Neisseria gonorrhoeae. Nucleic Acids Res (2005) 1.02
XerCD-mediated site-specific recombination leads to loss of the 57-kilobase gonococcal genetic island. J Bacteriol (2010) 0.97
Persistence of two genotypes of Neisseria gonorrhoeae during transmission. J Clin Microbiol (2003) 0.93
Insertion mutations in pilE differentially alter gonococcal pilin antigenic variation. J Bacteriol (1999) 0.88
Prevalence and detailed mapping of the gonococcal genetic island in Neisseria meningitidis. J Bacteriol (2012) 0.85
Genetic characterization of the nucleotide excision repair system of Neisseria gonorrhoeae. J Bacteriol (2009) 0.82
Analyzing Neisseria gonorrhoeae Pilin Antigenic Variation Using 454 Sequencing Technology. J Bacteriol (2016) 0.75
Neisseria gonorrhoeae Crippled Its Peptidoglycan Fragment Permease To Facilitate Toxic Peptidoglycan Monomer Release. J Bacteriol (2016) 0.75
Phase and antigenic variation govern competition dynamics through positioning in bacterial colonies. Sci Rep (2017) 0.75
NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. J Bacteriol (1963) 45.03
Amplification and analysis of DNA sequences in single human sperm and diploid cells. Nature (1988) 10.84
Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res (1989) 9.04
Pilus expression in Neisseria gonorrhoeae involves chromosomal rearrangement. Cell (1982) 7.19
Pilus genes of Neisseria gonorrheae: chromosomal organization and DNA sequence. Proc Natl Acad Sci U S A (1984) 5.37
Production of single-stranded DNA templates by exonuclease digestion following the polymerase chain reaction. Nucleic Acids Res (1989) 4.70
Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature (1985) 4.60
The repertoire of silent pilus genes in Neisseria gonorrhoeae: evidence for gene conversion. Cell (1986) 4.48
Analysis of heterogeneous viral populations by direct DNA sequencing. Biotechniques (1993) 2.65
Effects of recA mutations on pilus antigenic variation and phase transitions in Neisseria gonorrhoeae. Genetics (1987) 2.39
Antigenic variation of a relapsing fever Borrelia species. Annu Rev Microbiol (1990) 2.37
Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J Infect Dis (1981) 2.33
Interaction of two variable proteins (PilE and PilC) required for pilus-mediated adherence of Neisseria gonorrhoeae to human epithelial cells. Mol Microbiol (1992) 2.31
Species specificity of attachment and damage to oviduct mucosa by Neisseria gonorrhoeae. Infect Immun (1977) 1.67
Antigenic variation in African trypanosomes. Trends Genet (1992) 1.26
Studies of toxicity of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis (1981) 1.26
Creation of immunoglobulin diversity by intrachromosomal gene conversion. Trends Genet (1992) 1.18
Piliation changes in transformation-defective gonococci. J Exp Med (1990) 1.12
Loss of pili and decreased attachment to human cells by Neisseria meningitidis and Neisseria gonorrhoeae exposed to subinhibitory concentrations of antibiotics. Infect Immun (1984) 1.09
Effect of anti-pilus antisera on virulence of variants of Neisseria gonorrhoeae for cultured epithelial cells. J Gen Microbiol (1982) 1.01
Effect of anti-pilus antibodies on survival of gonococci within guinea pig subcutaneous chambers. Infect Immun (1982) 0.99
Paraffin beads can replace mineral oil as an evaporation barrier in PCR. Biotechniques (1993) 0.87
Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A (1992) 16.64
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med (1986) 10.91
Functional mapping of the human visual cortex by magnetic resonance imaging. Science (1991) 6.93
Sexual transmission of HIV. N Engl J Med (1997) 6.84
Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med (2000) 6.72
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci U S A (1995) 6.59
Shuttle mutagenesis: a method of transposon mutagenesis for Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1986) 5.75
The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med (1989) 5.02
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (2000) 4.91
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol (1989) 4.48
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol (1987) 3.61
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis (1998) 3.46
Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS (1997) 3.42
The microbicidal mechanisms of human neutrophils and eosinophils. Rev Infect Dis (1981) 3.29
Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis (1999) 3.12
Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol (1982) 3.11
The physical map of the chromosome of a serogroup A strain of Neisseria meningitidis shows complex rearrangements relative to the chromosomes of the two mapped strains of the closely related species N. gonorrhoeae. J Bacteriol (1995) 3.10
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Preventing sexual transmission of HIV--new ideas from sub-Saharan Africa. N Engl J Med (2000) 2.67
Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species. Infect Immun (1984) 2.65
Species-specific uptake of DNA by gonococci is mediated by a 10-base-pair sequence. J Bacteriol (1991) 2.64
The genetics of the gonococcus. Annu Rev Microbiol (1984) 2.63
Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle. J Infect Dis (1992) 2.62
Sexual transmission of HIV: infectiousness and prevention. AIDS (1999) 2.59
Antigenic variation of gonococcal pilus involves assembly of separated silent gene segments. Proc Natl Acad Sci U S A (1986) 2.53
Characterization of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro. J Infect Dis (1991) 2.53
Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS (1997) 2.51
Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J (1989) 2.47
Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect (2004) 2.43
Phase variation of gonococcal protein II: regulation of gene expression by slipped-strand mispairing of a repetitive DNA sequence. Cell (1989) 2.42
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41
The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol Microbiol (1998) 2.33
Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med (1981) 2.31
Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. Proc Natl Acad Sci U S A (1988) 2.27
Recombination among protein II genes of Neisseria gonorrhoeae generates new coding sequences and increases structural variability in the protein II family. Mol Microbiol (1988) 2.26
Differential roles of homologous recombination pathways in Neisseria gonorrhoeae pilin antigenic variation, DNA transformation and DNA repair. Mol Microbiol (1998) 2.24
Genetic mechanisms of bacterial antigenic variation. Microbiol Rev (1988) 2.22
Multiple biological activities of human recombinant interleukin 1. J Clin Invest (1986) 2.16
Characterization of the pilF-pilD pilus-assembly locus of Neisseria gonorrhoeae. Mol Microbiol (1995) 2.14
Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med (1990) 2.14
Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods (1996) 2.12
Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen. Infect Immun (1981) 2.09
Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect Immun (1992) 2.09
Closed reduction and percutaneous pinning of fractures of the proximal phalanx. J Hand Surg Br (2001) 2.07
Cloning of urease gene sequences from Providencia stuartii. Infect Immun (1986) 2.06
A variable genetic island specific for Neisseria gonorrhoeae is involved in providing DNA for natural transformation and is found more often in disseminated infection isolates. Mol Microbiol (2001) 2.06
Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 2.01
New concepts on the pathogenesis of fever. Rev Infect Dis (1988) 1.94
Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest (1994) 1.93
Qualitative and quantitative evaluation of six algorithms for correcting intensity nonuniformity effects. Neuroimage (2001) 1.90
Brain parenchyma motion: measurement with cine echo-planar MR imaging. Radiology (1992) 1.90
Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae. J Infect Dis (1986) 1.90
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis (2000) 1.89
Pilin expression in Neisseria gonorrhoeae is under both positive and negative transcriptional control. EMBO J (1988) 1.88
Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J Infect Dis (1994) 1.88
A homologue of the recombination-dependent growth gene, rdgC, is involved in gonococcal pilin antigenic variation. Genetics (2000) 1.83
Characterization of Neisseria gonorrhoeae protein II phase variation by use of monoclonal antibodies. Infect Immun (1984) 1.83
Gonococcal infection: a model of molecular pathogenesis. N Engl J Med (1985) 1.82
Growth conditions mediate differential transcription of fim genes involved in phase variation of type 1 pili. J Bacteriol (1992) 1.82
Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J Exp Med (1994) 1.80
Sexually transmitted diseases in the People's Republic of China in Y2K: back to the future. Sex Transm Dis (2000) 1.80
Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr (1990) 1.80
Genetic locus (nmp-1) affecting the principal outer membrane protein of Neisseria gonorrhoeae. J Bacteriol (1980) 1.80
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS (1999) 1.76
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Acquiring simultaneous EEG and functional MRI. Clin Neurophysiol (2000) 1.75
In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol (1989) 1.73
Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex Transm Dis (2001) 1.72
Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells. Eur J Immunol (1989) 1.72
Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol (1988) 1.70
Molecular models accounting for the gene conversion reactions mediating gonococcal pilin antigenic variation. Mol Microbiol (2000) 1.70
Increased plasma interleukin-1 activity in women after ovulation. Science (1985) 1.70
Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob Agents Chemother (1999) 1.68
Genetics of serum resistance in Neisseria gonorrhoeae: the sac-1 genetic locus. Infect Immun (1981) 1.67
Physical map of the chromosome of Neisseria gonorrhoeae FA1090 with locations of genetic markers, including opa and pil genes. J Bacteriol (1991) 1.65
Free radicals and phagocytic cells. FASEB J (1995) 1.65
Chancroid, primary syphilis, genital herpes, and lymphogranuloma venereum in Antananarivo, Madagascar. J Infect Dis (1999) 1.64
Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide. J Infect Dis (1984) 1.64
Adequacy of fellowship training: results of a survey of recently graduated fellows. Clin Infect Dis (2001) 1.63
A new deal in HIV prevention: lessons from the global approach. Ann Intern Med (1994) 1.63
Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J Infect Dis (1999) 1.62
Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol (2000) 1.60
Identification and characterization of a Neisseria gonorrhoeae gene encoding a glycolipid-binding adhesin. Proc Natl Acad Sci U S A (1990) 1.59
Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS (1998) 1.59
Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol Microbiol (1990) 1.58
Endogenous pyrogen activity in human plasma after exercise. Science (1983) 1.57
Metabolic changes following eccentric exercise in trained and untrained men. J Appl Physiol (1985) (1986) 1.56
Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol (1988) 1.56
The recX gene potentiates homologous recombination in Neisseria gonorrhoeae. Mol Microbiol (2001) 1.54